Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$267.08-2.04 (-0.76%)
Delayed quote: Sep 9, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 4:00 PM EDT
The latest quarterly capex is −$1.32 Billion with a QoQ Growth of -25.93%. Capital Expenditures (CapEx) represents spending on physical assets like property, plant, equipment, and technology infrastructure. It's the investment in the company's future productive capacity.
Reported quarterly capital expenditures; no daily interpolation. Q2 FY2026 (2026-06-28): $-1.32B.
−$1.32B
−$1.32 Billion
-25.93%
vs. −$1.05B prior quarter
96
Quarters of data available
| Period | CapEx | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-28 | −$1.32B | -25.93% | +5.51% |
| Q1 FY2026Period end 2026-03-29 | −$1.05B | +42.90% | -31.95% |
| Q4 FY2025Period end 2025-12-28 | −$1.84B | -133.12% | +14.36% |
| Q3 FY2025Period end 2025-09-28 | −$788.00M | +43.63% | +65.42% |
| Q2 FY2025Period end 2025-06-29 | −$1.40B | -75.85% | -43.24% |
| Q1 FY2025Period end 2025-03-30 | −$795.00M | +62.94% | +1.49% |
| Q4 FY2024Period end 2024-12-29 | −$2.15B | +5.88% | -34.99% |
| Q3 FY2024Period end 2024-09-29 | −$2.28B | -133.50% | -135.68% |
| Q2 FY2024Period end 2024-06-30 | −$976.00M | -20.94% | +13.17% |
| Q1 FY2024Period end 2024-03-31 | −$807.00M | +49.21% | +6.49% |
| Q4 FY2023Period end 2023-12-31 | −$1.59B | -64.32% | -0.13% |
| Q3 FY2023Period end 2023-10-01 | −$967.00M | +13.97% | -1.58% |
| Q2 FY2023Period end 2023-07-02 | −$1.12B | -30.24% | -30.24% |
| Q1 FY2023Period end 2023-04-02 | −$863.00M | +45.62% | -42.17% |
| Q4 FY2022Period end 2022-12-31 | −$1.59B | -66.70% | -12.16% |
| Q3 FY2022Period end 2022-10-02 | −$952.00M | -10.31% | -27.44% |
| Q2 FY2022Period end 2022-07-03 | −$863.00M | -42.17% | -6.15% |
| Q1 FY2022Period end 2022-04-03 | −$607.00M | +57.10% | +10.34% |
| Q4 FY2021Period end 2021-12-31 | −$1.42B | -89.42% | -6.95% |
| Q3 FY2021Period end 2021-10-03 | −$747.00M | +8.12% | -1.36% |
| Q2 FY2021Period end 2021-07-04 | −$813.00M | -20.09% | -22.81% |
| Q1 FY2021Period end 2021-04-04 | −$677.00M | +48.83% | -8.32% |
| Q4 FY2020Period end 2020-12-31 | −$1.32B | -79.51% | -5.00% |
| Q3 FY2020Period end 2020-09-27 | −$737.00M | -11.33% | +1.07% |
| Q2 FY2020Period end 2020-06-28 | −$662.00M | -5.92% | +20.91% |
| Q1 FY2020Period end 2020-03-29 | −$625.00M | +50.40% | +4.73% |
| Q4 FY2019Period end 2019-12-31 | −$1.26B | -69.13% | +4.40% |
| Q3 FY2019Period end 2019-09-29 | −$745.00M | +10.99% | +9.04% |
| Q2 FY2019Period end 2019-06-30 | −$837.00M | -27.59% | +4.34% |
| Q1 FY2019Period end 2019-03-31 | −$656.00M | +50.23% | +0.30% |
| Q4 FY2018Period end 2018-12-31 | −$1.32B | -60.93% | -6.29% |
| Q3 FY2018Period end 2018-09-30 | −$819.00M | +6.40% | -3.67% |
| Q2 FY2018Period end 2018-07-01 | −$875.00M | -32.98% | -27.00% |
| Q1 FY2018Period end 2018-04-01 | −$658.00M | +46.94% | -17.50% |
| Q4 FY2017Period end 2017-12-31 | −$1.24B | -56.96% | -13.45% |
| Q3 FY2017Period end 2017-10-01 | −$790.00M | -14.66% | -7.19% |
| Q2 FY2017Period end 2017-07-02 | −$689.00M | -23.04% | +8.98% |
| Q1 FY2017Period end 2017-04-02 | −$560.00M | +48.76% | +12.36% |
| Q4 FY2016Period end 2016-12-31 | −$1.09B | -48.30% | +19.99% |
| Q3 FY2016Period end 2016-10-02 | −$737.00M | +2.64% | +6.59% |
| Q2 FY2016Period end 2016-07-03 | −$757.00M | -18.47% | +1.05% |
| Q1 FY2016Period end 2016-04-03 | −$639.00M | +53.22% | -17.68% |
| Q4 FY2015Period end 2015-12-31 | −$1.37B | -73.13% | +8.69% |
| Q3 FY2015Period end 2015-09-27 | −$789.00M | -3.14% | -5.06% |
| Q2 FY2015Period end 2015-06-28 | −$765.00M | -40.88% | +8.60% |
| Q1 FY2015Period end 2015-03-29 | −$543.00M | +63.70% | +13.81% |
| Q4 FY2014Period end 2014-12-31 | −$1.50B | -99.20% | -4.69% |
| Q3 FY2014Period end 2014-09-28 | −$751.00M | +10.27% | +7.17% |
| Q2 FY2014Period end 2014-06-29 | −$837.00M | -32.86% | -8.56% |
| Q1 FY2014Period end 2014-03-30 | −$630.00M | +55.91% | -7.51% |
| Q4 FY2013Period end 2013-12-31 | −$1.43B | -76.64% | -24.05% |
| Q3 FY2013Period end 2013-09-29 | −$809.00M | -4.93% | -18.62% |
| Q2 FY2013Period end 2013-06-30 | −$771.00M | -31.57% | -28.93% |
| Q1 FY2013Period end 2013-03-31 | −$586.00M | +49.13% | -16.73% |
| Q4 FY2012Period end 2012-12-31 | −$1.15B | -68.91% | -2.13% |
| Q3 FY2012Period end 2012-09-30 | −$682.00M | -14.05% | +4.08% |
| Q2 FY2012Period end 2012-07-01 | −$598.00M | -19.12% | +3.24% |
| Q1 FY2012Period end 2012-04-01 | −$502.00M | +55.50% | -15.14% |
| Q4 FY2011Period end 2011-12-31 | −$1.13B | -58.65% | -17.62% |
| Q3 FY2011Period end 2011-10-02 | −$711.00M | -15.05% | -34.66% |
| Q2 FY2011Period end 2011-07-03 | −$618.00M | -41.74% | -23.60% |
| Q1 FY2011Period end 2011-04-03 | −$436.00M | +54.54% | -9.82% |
| Q4 FY2010Period end 2010-12-31 | −$959.00M | -81.63% | -13.63% |
| Q3 FY2010Period end 2010-10-03 | −$528.00M | -5.60% | -1.73% |
| Q2 FY2010Period end 2010-07-04 | −$500.00M | -25.94% | +11.82% |
| Q1 FY2010Period end 2010-04-04 | −$397.00M | +52.96% | +8.74% |
| Q4 FY2009Period end 2009-12-31 | −$844.00M | -62.62% | +22.71% |
| Q3 FY2009Period end 2009-09-27 | −$519.00M | +8.47% | +35.77% |
| Q2 FY2009Period end 2009-06-28 | −$567.00M | -30.34% | +14.74% |
| Q1 FY2009Period end 2009-03-29 | −$435.00M | +60.16% | +13.17% |
| Q4 FY2008Period end 2008-12-31 | −$1.09B | -35.15% | +27.44% |
| Q3 FY2008Period end 2008-09-28 | −$808.00M | -21.50% | -13.64% |
| Q2 FY2008Period end 2008-06-29 | −$665.00M | -32.73% | -9.38% |
| Q1 FY2008Period end 2008-03-30 | −$501.00M | +66.71% | -3.09% |
| Q4 FY2007Period end 2007-12-31 | −$1.50B | -111.67% | -49.45% |
| Q3 FY2007Period end 2007-09-30 | −$711.00M | -16.94% | -2.01% |
| Q2 FY2007Period end 2007-07-01 | −$608.00M | -25.10% | -3.40% |
| Q1 FY2007Period end 2007-04-01 | −$486.00M | +51.74% | -8.97% |
| Q4 FY2006Period end 2006-12-31 | −$1.01B | -44.48% | +11.82% |
| Q3 FY2006Period end 2006-10-01 | −$697.00M | -18.54% | -13.15% |
| Q2 FY2006Period end 2006-07-02 | −$588.00M | -31.84% | -23.27% |
| Q1 FY2006Period end 2006-04-02 | −$446.00M | +60.95% | -12.34% |
| Q4 FY2005Period end 2005-12-31 | −$1.14B | -85.39% | -10.55% |
| Q3 FY2005Period end 2005-10-02 | −$616.00M | -29.14% | -43.93% |
| Q2 FY2005Period end 2005-07-03 | −$477.00M | -20.15% | -13.03% |
| Q1 FY2005Period end 2005-04-03 | −$397.00M | +61.57% | -35.96% |
| Q4 FY2004Period end 2004-12-31 | −$1.03B | -141.36% | -30.76% |
| Q3 FY2004Period end 2004-09-26 | −$428.00M | -1.42% | +23.30% |
| Q2 FY2004Period end 2004-06-27 | −$422.00M | -44.52% | +16.60% |
| Q1 FY2004Period end 2004-03-28 | −$292.00M | +63.04% | +28.43% |
| Q4 FY2003Period end 2003-12-31 | −$790.00M | -41.58% | +1.25% |
| Q3 FY2003Period end 2003-09-28 | −$558.00M | -10.28% | -12.27% |
| Q2 FY2003Period end 2003-06-29 | −$506.00M | -24.02% | N/A |
| Q1 FY2003Period end 2003-03-30 | −$408.00M | +49.00% | N/A |
| Q4 FY2002Period end 2002-12-31 | −$800.00M | -60.97% | N/A |
| Q3 FY2002Period end 2002-09-29 | −$497.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.